Letters
Drug regulation data
UK drug regulator destroys all evidence after 15 years
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4203 (Published 05 July 2011) Cite this as: BMJ 2011;343:d4203
- Peter C Gøtzsche, professor and director1
- 1Nordic Cochrane Centre, Rigshospitalet, DK-2100 Copenhagen Ø, Denmark
- pcg{at}cochrane.dk
Jørgensen and I recently gained access to clinical study reports and trial protocols of placebo controlled trials at the European Medicines Agency (EMA).1 Some drugs, however, have not been approved centrally, and in such cases the EMA advises contacting the relevant national drug agencies.
For the antidepressant drug fluoxetine, the United Kingdom acts as Reference Member State according to the Mutual Recognition …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.